Osaic Holdings
BLTE

Osaic Holdings’s Belite Bio BLTE Stock Holding History

Osaic Holdings’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-195
Closed -$31.2K – 7833
2025
Q4 		$31.2K Buy
195
+192
+6,400% +$22.7K ﹤0.01% 5564
2025
Q3 		$222 Sell
3
-3
-50% -$197 ﹤0.01% 7685
2025
Q2 		$346 Hold
6
– – ﹤0.01% 7416
2025
Q1 		$397 Sell
6
-1
-14% -$60 ﹤0.01% 7049
2024
Q4 		$442 Sell
7
-1
-13% -$66 ﹤0.01% 7047
2024
Q3 		$375 Hold
8
– – ﹤0.01% 7059
2024
Q2 		$365 Buy
8
+3
+60% +$130 ﹤0.01% 7064
2024
Q1 		$192 Sell
5
-31
-86% -$1.39K ﹤0.01% 6965
2023
Q4 		$1.65K Buy
+36
New +$1.38K ﹤0.01% 6596

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings's BLTE Position: Q1 2026 in Review

Osaic Holdings sold out of Belite Bio (BLTE) in Q1 2026, closing a stake of 195 shares — an estimated $31.2K sold.

Osaic Holdings first reported a position in BLTE in Q4 2023 and held it in 9 quarters. The position peaked at $31.2K in Q4 2025. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • Osaic Holdings reported no remaining Belite Bio position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 195 Belite Bio shares in Q1 2026, an estimated $31.2K.
  • Osaic Holdings first reported a position in Belite Bio in Q4 2023 and held it in 9 quarters.
  • Osaic Holdings's Belite Bio position peaked at $31.2K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.